Select Page

Areas of Focus

Hundreds of studies using adipose-derived stem and regenerative cells (ADRCs)—from mice to large animals to humans—across a broad spectrum of conditions have reported safety and signals of effectiveness in improving symptoms, function and quality of life for patients with chronic degenerative diseases. [1] [2] [3]

The following are key examples of areas we are currently focusing on with the use of experimental adult stem cell treatments for patients that have been diagnosed with a terminal illness or severe chronic disease.

To learn more about becoming patient of AMBROSE Cell Therapy, please click here.

Autoimmune

Immune-mediated disorders such as rheumatoid arthritis, multiple sclerosis and lupus.

Orthopedics

Sports injuries, osteoarthritis, back pain and other musculoskeletal issues.

Neurological

Including Parkinson’s, Alzheimer’s, traumatic brain injury and stroke.

Neuropathies

Dysfunction of peripheral nerves resulting in pain, numbness and loss of function.

Diabetes

Both Type 1 and Type 2 diabetes as well as related complications and symptoms.

Kidney Disease

Chronic kidney disease or failure leading to the gradual loss of function of the organs.

IBD

Inflammatory bowel diseases including ulcerative colitis, Crohn’s and IBS.

Men’s Health

Issues affecting men including benign prostatic hyperplasia, ED and others.

Spinal Cord Injury

Our goal is improvement in symptoms, function and quality of life after Spinal cord injuries.

[1]JK Fraser PhD and S. Kesten MD Autologous Adipose Derived Regenerative Cells: A platform for therapeutic applications Advanced Wound Healing Surgical Technology International XXIX

[2] A Nguyen, A et al Stromal vascular fraction: A regenerative reality? Part 1: Current concepts and review of the literature Journal of Plastic, Reconstructive & Aesthetic Surgery (2016) 69, 170e179

[3] Guo et al Stromal vascular fraction: A regenerative reality? Part 2: Current concepts and review of the literature Journal of Plastic, Reconstructive & Aesthetic Surgery (2016) 69, 180e188

AMBROSE Cell Therapy

Your Right to Try